SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Charts for Quick CASH $$$

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (7539)5/4/1998 1:25:00 AM
From: N/E PATSFAN  Read Replies (2) of 9262
 
[ ENMD ]

Rick! You here tonite ?

Have you got any thoughts on the endo/angio-statin excitement. I wonder if SUGN isn't further along with research:

sec.yahoo.com

Snip> The Company is also conducting its initial Phase I clinical trial for its second cancer product candidate, SU5416, a Flk-1/KDR TK antagonist which inhibits angiogenesis (the process by which blood vessels are formed). <

Regards, NEPF

P.S. My niece just went to work for ARIA from GENE to head up a new project ... I'll have to pick her brain the next time I see her.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext